Onyx Pharmaceuticals Inc (ONXX)

[chmcnfunds]

Bayer Seeks US, EU Approval for Nexavar to Treat Thyroid Cancer

By Dow Jones Business News, July 01, 2013, 03:14:00 AM EDT
Vote up


Bayer AG (BAYN.XE) said Monday it is seeking approval from the U.S. and the E.U. to use its drug Nexavar to treat thyroid cancer.

MAIN FACTS:
-Nexavar, also known as sorafenib, is an oral drug developed and marketed by Bayer HealthCareand Onyx Pharmaceuticals Inc. ( ONXX ).
-The companies have applied to the U.S. Food & Drug Administration and the European Medicines Agency to use the drug to treat localized, advanced thyroid cancer or metastasis.
-"Especially for patients in the advanced stage, treatment options are lacking or very limited," Bayer's head of global development Dr. Kemal Malik said.
-Nexavar is already approved to treat liver cell cancer and advanced kidney cancer, Bayer said.
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500
Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires
07-01-130314ET
Copyright (c) 2013 Dow Jones & Company, Inc.

Read more: http://www.nasdaq.com/article/bayer-seeks-us-eu-approval-for-nexavar-to-treat-thyroid-cancer-20130701-00046#ixzz2XnB7sRgU
_______________________________________________________

ONXX